Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 3,000 $ 2,570,000 $ (2,502,000) $ 71,000
Balance (in Shares) at Dec. 31, 2020 2,838,047      
Share-based compensation $ 0 69,000 0 69,000
Restricted stock vesting $ 0 20,000 0 20,000
Restricted stock vesting (in shares) 0      
Issuances of common stock, net of issuance costs $ 0 285,000 0 285,000
Issuances of common stock, net of issuance costs (in shares) 101,800      
Warrants issued for debt issuance $ 0 (17,000) 0 (17,000)
Beneficial conversion and warrant features of convertible debt 0 1,276,000 0 1,276,000
Net loss 0 0 (704,000) (704,000)
Balance at Mar. 31, 2021 $ 3,000 4,203,000 (3,206,000) 1,000,000
Balance (in Shares) at Mar. 31, 2021 2,939,847      
Balance at Dec. 31, 2021 $ 6,000 18,891,000 (6,812,000) 12,085,000
Balance (in Shares) at Dec. 31, 2021 5,572,234      
Share-based compensation   55,000   55,000
Net loss     (1,836,000) (1,836,000)
Balance at Mar. 31, 2022 $ 6,000 $ 18,946,000 $ (8,648,000) $ 10,304,000
Balance (in Shares) at Mar. 31, 2022 5,572,234